Japan approves expanded reimbursement coverage for Abbott’s FreeStyle Libre CGM

Abbott’s FreeStyle Libre 14 day continuous glucose monitoring system [Image courtesy of Abbott]Abbott (NYSE:ABT) announced today that it received expanded reimbursement coverage in Japan for the FreeStyle Libre system.

Japan’s Ministry of Health, Labour and Welfare approved the expansion for the continuous glucose monitoring (CGM) system to include all people with diabetes who use insulin at least once per day.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

J&J Vision wins Japanese approval for first drug-releasing contact lens

Johnson & Johnson Vision announced that it received approval in Japan for its Acuvue Theravision lens with Ketotifen.

The company touts the lens as the first and only vision-correcting contact lens that relieves allergic eye itch through drug delivery, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0